Literature DB >> 8032000

Expression of tumour necrosis factor-alpha, -beta and interferon-gamma genes within human neuroglial tumour cells and brain specimens.

T Nitta1, M Ebato, K Sato, K Okumura.   

Abstract

Expression of cytokine genes, TNF-alpha, TNF-beta and IFN-gamma, in human astroglial cell lines and in fresh brain specimens was studied by PCR. mRNA transcripts of TNF-alpha could be detected in three out of five astrocytomas and neuroblastoma cell lines, and after stimulation with IL-1 beta/IFN-gamma or LPS/IFN-gamma all these cell lines expressed TNF-alpha genes. TNF-beta genes could not be detected in these cell lines. We were able to detect expression of IFN-gamma genes within two astrocytoma cell lines, which interestingly did not show TNF-alpha activity. In addition to the cultured cells, we also examined gene expression of these cytokines within four human malignant astrocytoma specimens, two peritumoral brain and two autopsied normal brains. The results show that tumour and surrounding reactive lesions express TNF-alpha genes (four of six) but not normal brains. The concentration of these cytokines in the supernatant of cultured cells was measured quantitatively by TNF-alpha, -beta or IFN-gamma ELISA. The combined stimulation of these neuroglial cell lines with IL-1 beta and LPS or IFN-gamma, revealed a high level of TNF-alpha activity. This was especially evident with a neuroblastoma cell line. The concentration of TNF-alpha in the supernatant of the IMR32 neuroblastoma cell line increased markedly upon stimulation with IL-1 beta in both a time- and dose-dependent fashion in the presence of LPS or IFN-gamma. Next, we examined expression of IL-1 beta and IFN-gamma genes in the brain specimens. The result shows that four in six tumour and peritumoral regions expressed IFN-gamma genes and one specimen showed IL-beta gene by PCR. From these experiments it is suspected that neuroglial cell-derived TNF-alpha induced by IL-1 beta of IFN-gamma may participate in local immune reactions of the brain in an autocrine and paracrine fashion.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8032000     DOI: 10.1016/1043-4666(94)90039-6

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  9 in total

Review 1.  Current status and challenges of cytokine pharmacology.

Authors:  Z Zídek; P Anzenbacher; E Kmonícková
Journal:  Br J Pharmacol       Date:  2009-04-03       Impact factor: 8.739

Review 2.  The multifaceted profile of activated microglia.

Authors:  Marina A Lynch
Journal:  Mol Neurobiol       Date:  2009-07-23       Impact factor: 5.590

3.  Receptors for advanced glycosylation endproducts in human brain: role in brain homeostasis.

Authors:  J J Li; D Dickson; P R Hof; H Vlassara
Journal:  Mol Med       Date:  1998-01       Impact factor: 6.354

Review 4.  Cytokine gene expression within the central nervous system.

Authors:  T Nitta
Journal:  Cell Mol Neurobiol       Date:  1998-12       Impact factor: 5.046

5.  Atorvastatin prevents age-related and amyloid-β-induced microglial activation by blocking interferon-γ release from natural killer cells in the brain.

Authors:  Anthony Lyons; Kevin J Murphy; Rachael Clarke; Marina A Lynch
Journal:  J Neuroinflammation       Date:  2011-03-31       Impact factor: 8.322

6.  Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis.

Authors:  Norbert Gerdes; Galina K Sukhova; Peter Libby; Rebecca S Reynolds; James L Young; Uwe Schönbeck
Journal:  J Exp Med       Date:  2002-01-21       Impact factor: 14.307

7.  The level of MnSOD is directly correlated with grade of brain tumours of neuroepithelial origin.

Authors:  M Landriscina; F Remiddi; F Ria; B Palazzotti; M E De Leo; M Iacoangeli; R Rosselli; M Scerrati; T Galeotti
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

8.  Low-dose interferon-gamma-producing human neuroblastoma cells show reduced proliferation and delayed tumorigenicity.

Authors:  I Airoldi; R Meazza; M Croce; E Di Carlo; T Piazza; C Cocco; T D'Antuono; V Pistoia; S Ferrini; M V Corrias
Journal:  Br J Cancer       Date:  2004-06-01       Impact factor: 7.640

9.  High diluted molecules and gene expression.

Authors:  Salvatore Chirumbolo
Journal:  Front Pharmacol       Date:  2014-08-14       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.